Literature DB >> 21552191

Repetitive transcranial magnetic stimulation and treatment of negative symptoms of schizophrenia.

Radovan Prikryl1.   

Abstract

One of the fundamental prerequisites of the successful schizophrenia treatment is represented by an adequately significant impact on the negative symptoms of schizophrenia. Since the present pharmacotherapy has probably reached its limit in this area, there is a logical effort to utilize other, non-pharmacological methods. One of the most promising supplements that has been for a long time verified in the clinical practice is rTMS. Most of the studies have arrived at the conclusion that rTMS is an efficient method in the treatment of negative symptoms of schizophrenia. A valuable contribution to the assessment of the rTMS application in the treatment of negative symptoms is represented by meta-analyses. The meta-analyses indicate that the effect is mild to moderate (d=0.43 to 0.68). To sum it up, there will be higher probability of the rTMS effect on negative symptoms if 10 Hz stimulating frequency and a longer stimulation period in the extent at least three, ideally four to six weeks is used.

Entities:  

Mesh:

Year:  2011        PMID: 21552191

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  3 in total

Review 1.  Current Status of Neuromodulation-Induced Cortical Prehabilitation and Considerations for Treatment Pathways in Lower-Grade Glioma Surgery.

Authors:  Ryan P Hamer; Tseng Tsai Yeo
Journal:  Life (Basel)       Date:  2022-03-22

Review 2.  Dopamine D4 receptor gene DRD4 and its association with psychiatric disorders.

Authors:  Radek Ptácek; Hana Kuzelová; George B Stefano
Journal:  Med Sci Monit       Date:  2011-09

Review 3.  Treating Negative Symptoms in Schizophrenia: an Update.

Authors:  Gary Remington; George Foussias; Gagan Fervaha; Ofer Agid; Hiroyoshi Takeuchi; Jimmy Lee; Margaret Hahn
Journal:  Curr Treat Options Psychiatry       Date:  2016-04-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.